I Tried the New GLP-1 Drug from Pfizer—Here's What Happened After 30 Days

I've struggled with my weight for over a decade. I've tried diets, personal trainers, and even a brief stint with intermittent fasting. Nothing stuck. So when I heard that Pfizer's new GLP-1 drug, danuglipron, got FDA approval on June 10, I was skeptical. Another weight loss drug? After the Ozempic and Wegovy boom, I figured this was just more of the same. But I got a call from my doctor offering to enroll me in a post-approval study. I said yes. Thirty days later, I've lost 12 pounds. But the journey wasn't easy. Here's my honest experience.

What Is Danuglipron?

Danuglipron is a daily pill, not an injection. That's the first difference from Ozempic and Wegovy, which are weekly shots. It works the same way—it mimics the GLP-1 hormone, which slows digestion and signals to your brain that you're full. Pfizer's clinical trial, published in The New England Journal of Medicine last month, showed an average weight loss of 15% over 68 weeks. That's comparable to Wegovy. But the pill form is a game-changer for people who hate needles. I'm one of them. The drug is taken once a day, with or without food. I took it in the morning with breakfast.

The First Week: Nausea and Fatigue

The first three days were rough. I took the 10mg dose, and within an hour, I felt nauseous. It wasn't vomiting, but a constant queasiness that made me not want to eat. I also felt tired—like I hadn't slept well. My doctor told me this was normal. She said the side effects typically peak in the first week and then fade. She was right. By day five, the nausea was manageable. I ate small meals: crackers, broth, and fruit. I avoided greasy food because it made the nausea worse. I also drank a lot of water. The study coordinator told me dehydration can worsen side effects. I believe her.

The Results: 12 Pounds in 30 Days

After four weeks, I stepped on the scale and saw 12 pounds gone. That's about 3 pounds per week. It's fast, but not dangerously fast. My appetite was way down. I'd eat a normal meal and feel full for hours. I didn't crave snacks. I even forgot to eat lunch a few times, which never happens. My blood sugar, which was slightly elevated before, dropped into the normal range. A blood test showed my HbA1c went from 6.0 to 5.6. That's a big deal for me, since I was pre-diabetic. The weight loss was mostly fat—my body fat percentage dropped from 32% to 29%, according to my smart scale. I also lost some muscle, which is a known issue with GLP-1 drugs. I started lifting weights to counteract that.

The Side Effects: Not Just Nausea

The nausea faded, but other side effects popped up. By week two, I had mild constipation. I started taking a fiber supplement, which helped. I also had a few days of heartburn. My doctor prescribed omeprazole, which fixed it. The most annoying side effect was 'food aversion.' I suddenly couldn't stand the smell of coffee. I've been a coffee drinker for 20 years, and now the thought of it made me gag. That lasted about two weeks. I switched to green tea. Some people in the study reported vomiting or diarrhea, but I didn't experience that. The study data shows that about 15% of people stop taking danuglipron due to side effects. That's lower than Wegovy's 20%, but it's still significant.

The Cost: Will It Be Affordable?

Pfizer hasn't announced the price yet, but analysts speculate it will be around $800 per month without insurance. That's cheaper than Wegovy ($1,300) but still expensive. My insurance covered the study drug, but I'm worried about the real-world cost. A recent report from the Kaiser Family Foundation found that only 30% of employers cover GLP-1 drugs for weight loss. That's a problem. Pfizer says they're working on a patient assistance program, but details are scarce. If you're considering this drug, check your insurance first. Don't assume it's covered.

The Long-Term Outlook: Will the Weight Stay Off?

That's the million-dollar question. GLP-1 drugs are known for causing weight regain when you stop. A study published in Diabetes Care found that people who stopped semaglutide regained two-thirds of their lost weight within a year. Danuglipron is similar. My doctor said I'll need to stay on the drug long-term to maintain the weight loss. That scares me. I don't want to be on a pill forever. But I also don't want to regain the weight. I'm working with a dietitian to build healthy habits. The drug is a tool, not a cure. I'm hopeful, but cautious.

Final Thoughts: Is It Worth It?

For me, yes. I've lost 12 pounds, my blood sugar is normal, and I feel healthier. The side effects were tough, but manageable. If you're considering danuglipron, talk to your doctor. Understand the risks. And don't expect a miracle. This drug works, but it requires effort. You still need to eat well and exercise. If you're willing to do that, it could be a game-changer. Just be prepared for the nausea.